Intermountain Healthcare's - PRECISion MEdicine Biobank
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 100,000
- 试验地点
- 1
- 主要终点
- Biobank for precision genomics
研究概览
简要总结
The immediate goal of this study is to collect biological samples (i.e., tissue and/or fluid), clinical information, and laboratory data from disease and non-disease subjects seen at Intermountain Healthcare affiliated facilities. The long-term goal is to annotate tissue and/or fluid biomarker data to clinical information and laboratory data for the purpose of improving health care delivery and prognostic potential.
详细描述
This study consists of an observational, non-randomized, open, long-term study in diseased and non-diseased subjects. There are no investigational treatments, drugs, or procedures associated with subject participation. This study will consist of two groups:
- Group #1: Diseased subjects (including COVID-19 known positive subjects)
- Group #2: Non-diseased subjects
The biological samples collected may be tested numerous times for genes/biomarkers, and not yet-discovered genes/biomarkers, and other genetic and biological materials associated with healthcare-related conditions. In some cases, cells or tissues may be maintained in culture in order to study functions of living cells in both a healthy and diseased state.
Disease subjects who qualify for this project (see inclusion and exclusion criteria) will continue with their usual or specialized care for their underlying health-care related condition(s).
Disease subjects (Group #1)
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Biobank for precision genomics
时间窗: Day 0
There are no primary endpoints planned for this biobank and endpoints will be specific to future research hypotheses. Investigators anticipate examining genetic and genomic data using a variety of molecular and cellular analysis techniques and in various tissues and fluids.
Biobank for precision transcriptomics
时间窗: Day 0
There are no primary endpoints planned for this biobank and endpoints will be specific to future research hypotheses. Investigators anticipate examining transcriptomic data using a variety of molecular and cellular analysis techniques and in various tissues and fluids.
Biobank for precision proteomics
时间窗: Day 0
There are no primary endpoints planned for this biobank and endpoints will be specific to future research hypotheses. Investigators anticipate examining proteomic data using a variety of molecular and cellular analysis techniques and in various tissues and fluids.
次要结局
未报告次要终点
研究者
Tyler Barker, PhD
Senior Scientist
Intermountain Health Care, Inc.